In contrast, Li et al.60 reported that hepatocyte-specific METTL3 deletion drives NAFLD-to-NASH progression by enhancing CD36-mediated hepatic-free FA uptake and CCL2-induced inflammation. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.